1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What Is This Report About? 11
2.2 Advanced Wound Management Market Segmentation 11
2.3 Definitions of Markets Covered in the Report 13
3 Advanced Wound Management Market, North America 17
3.1 Advanced Wound Management Market, North America, Revenue ($m), 2015-2025 17
3.2 Advanced Wound Management Market, North America, Revenue ($m), 2015-2025 19
3.3 Advanced Wound Management Market, North America, Volume (Units), 2015-2025 22
3.4 Advanced Wound Management Market, North America, Volume (Units), 2015-2025 24
3.5 Advanced Wound Management Market, North America, Company Share by Revenue ($m), 2019 27
4 Advanced Wound Management Market, Canada 29
4.1 Advanced Wound Management Market, Canada, Revenue ($m), 2015-2025 29
4.1.1 Alginates Market, Canada, Revenue ($m), by Segment, 2015-2025 32
4.1.2 Collagens Market, Canada, Revenue ($m), by Segment, 2015-2025 34
4.1.3 Foams Market, Canada, Revenue ($m), by Segment, 2015-2025 36
4.1.4 Hydrocolloids Market, Canada, Revenue ($m), by Segment, 2015-2025 38
4.1.5 Hydrofibres Market, Canada, Revenue ($m), by Segment, 2015-2025 40
4.1.6 Hydrogels Market, Canada, Revenue ($m), by Segment, 2015-2025 42
4.1.7 Semi-Permeable Films Market, Canada, Revenue ($m), by Segment, 2015-2025 44
4.1.8 Superabsorbents Market, Canada, Revenue ($m), by Segment, 2015-2025 46
4.1.9 Wound Contact Layers Market, Canada, Revenue ($m), by Segment, 2015-2025 48
4.2 Advanced Wound Management Market, Canada, Volume (Units), 2015-2025 50
4.2.1 Alginates Market, Canada, Volume (Units), by Segment, 2015-2025 53
4.2.2 Collagens Market, Canada, Volume (Units), by Segment, 2015-2025 55
4.2.3 Foams Market, Canada, Volume (Units), by Segment, 2015-2025 57
4.2.4 Hydrocolloids Market, Canada, Volume (Units), by Segment, 2015-2025 59
4.2.5 Hydrofibres Market, Canada, Volume (Units), by Segment, 2015-2025 61
4.2.6 Hydrogels Market, Canada, Volume (Units), by Segment, 2015-2025 63
4.2.7 Semi-Permeable Films Market, Canada, Volume (Units), by Segment, 2015-2025 65
4.2.8 Superabsorbents Market, Canada, Volume (Units), by Segment, 2015-2025 67
4.2.9 Wound Contact Layers Market, Canada, Volume (Units), by Segment, 2015-2025 69
4.3 Advanced Wound Management Market, Canada, Average Price ($) , 2015-2025 71
4.4 Advanced Wound Management Market, Canada, Distribution Share by Revenue ($m), 2019 75
4.5 Advanced Wound Management Market, Canada, Company Share by Revenue ($m), 2019 76
5 Advanced Wound Management Market, Mexico 78
5.1 Advanced Wound Management Market, Mexico, Revenue ($m), 2015-2025 78
5.1.1 Alginates Market, Mexico, Revenue ($m), by Segment, 2015-2025 81
5.1.2 Collagens Market, Mexico, Revenue ($m), by Segment, 2015-2025 83
5.1.3 Foams Market, Mexico, Revenue ($m), by Segment, 2015-2025 85
5.1.4 Hydrocolloids Market, Mexico, Revenue ($m), by Segment, 2015-2025 87
5.1.5 Hydrofibres Market, Mexico, Revenue ($m), by Segment, 2015-2025 89
5.1.6 Hydrogels Market, Mexico, Revenue ($m), by Segment, 2015-2025 91
5.1.7 Semi-Permeable Films Market, Mexico, Revenue ($m), by Segment, 2015-2025 93
5.1.8 Superabsorbents Market, Mexico, Revenue ($m), by Segment, 2015-2025 95
5.1.9 Wound Contact Layers Market, Mexico, Revenue ($m), by Segment, 2015-2025 97
5.2 Advanced Wound Management Market, Mexico, Volume (Units), 2015-2025 99
5.2.1 Alginates Market, Mexico, Volume (Units), by Segment, 2015-2025 102
5.2.2 Collagens Market, Mexico, Volume (Units), by Segment, 2015-2025 104
5.2.3 Foams Market, Mexico, Volume (Units), by Segment, 2015-2025 106
5.2.4 Hydrocolloids Market, Mexico, Volume (Units), by Segment, 2015-2025 108
5.2.5 Hydrofibres Market, Mexico, Volume (Units), by Segment, 2015-2025 110
5.2.6 Hydrogels Market, Mexico, Volume (Units), by Segment, 2015-2025 112
5.2.7 Semi-Permeable Films Market, Mexico, Volume (Units), by Segment, 2015-2025 114
5.2.8 Superabsorbents Market, Mexico, Volume (Units), by Segment, 2015-2025 116
5.2.9 Wound Contact Layers Market, Mexico, Volume (Units), by Segment, 2015-2025 118
5.3 Advanced Wound Management Market, Mexico, Average Price ($) , 2015-2025 120
5.4 Advanced Wound Management Market, Mexico, Distribution Share by Revenue ($m), 2019 124
5.5 Advanced Wound Management Market, Mexico, Company Share by Revenue ($m), 2019 125
6 Advanced Wound Management Market, United States 127
6.1 Advanced Wound Management Market, United States, Revenue ($m), 2015-2025 127
6.1.1 Alginates Market, United States, Revenue ($m), by Segment, 2015-2025 130
6.1.2 Collagens Market, United States, Revenue ($m), by Segment, 2015-2025 132
6.1.3 Foams Market, United States, Revenue ($m), by Segment, 2015-2025 134
6.1.4 Hydrocolloids Market, United States, Revenue ($m), by Segment, 2015-2025 136
6.1.5 Hydrofibres Market, United States, Revenue ($m), by Segment, 2015-2025 138
6.1.6 Hydrogels Market, United States, Revenue ($m), by Segment, 2015-2025 140
6.1.7 Semi-Permeable Films Market, United States, Revenue ($m), by Segment, 2015-2025 142
6.1.8 Superabsorbents Market, United States, Revenue ($m), by Segment, 2015-2025 144
6.1.9 Wound Contact Layers Market, United States, Revenue ($m), by Segment, 2015-2025 146
6.2 Advanced Wound Management Market, United States, Volume (Units), 2015-2025 148
6.2.1 Alginates Market, United States, Volume (Units), by Segment, 2015-2025 151
6.2.2 Collagens Market, United States, Volume (Units), by Segment, 2015-2025 153
6.2.3 Foams Market, United States, Volume (Units), by Segment, 2015-2025 155
6.2.4 Hydrocolloids Market, United States, Volume (Units), by Segment, 2015-2025 157
6.2.5 Hydrofibres Market, United States, Volume (Units), by Segment, 2015-2025 159
6.2.6 Hydrogels Market, United States, Volume (Units), by Segment, 2015-2025 161
6.2.7 Semi-Permeable Films Market, United States, Volume (Units), by Segment, 2015-2025 163
6.2.8 Superabsorbents Market, United States, Volume (Units), by Segment, 2015-2025 165
6.2.9 Wound Contact Layers Market, United States, Volume (Units), by Segment, 2015-2025 167
6.3 Advanced Wound Management Market, United States, Average Price ($) , 2015-2025 169
6.4 Advanced Wound Management Market, United States, Distribution Share by Revenue ($m), 2019 173
6.5 Advanced Wound Management Market, United States, Company Share by Revenue ($m), 2019 174
7 Overview of Key Companies in North America Advanced Wound Management Market 176
7.1 Smith & Nephew Plc 176
7.1.1 Company Overview 176
7.2 Molnlycke Health Care AB 176
7.2.1 Company Overview 176
7.3 ConvaTec Group Plc 176
7.3.1 Company Overview 176
7.4 3M Co 177
7.4.1 Company Overview 177
7.5 Coloplast A/S 177
7.5.1 Company Overview 177
7.6 Acelity Holdings, Inc. (Inactive) 177
7.6.1 Company Overview 177
7.7 B. Braun Melsungen AG 178
7.7.1 Company Overview 178
7.8 BSN medical GmbH 178
7.8.1 Company Overview 178
7.9 Lohmann & Rauscher GmbH & Co. KG 178
7.9.1 Company Overview 178
8 Advanced Wound Management Market Pipeline Products 179
9 Recent Developments 191
9.1 Corporate Communications 191
9.1.1 Feb 21, 2020: Tenax announces the addition of Mayo Clinic expert, Dr. Barry Borlaug, to Scientific Advisory Board 191
9.1.2 Feb 14, 2020: CollPlant Biotechnologies raising $4.45 million in U.S. Private Placement 191
9.1.3 Feb 06, 2020: Henry Ford Health System announces new president and CEO Of Health Alliance Plan 192
9.1.4 Feb 04, 2020: Henry Ford Medical Group names new Chair of Board of Governors 192
9.1.5 Jan 28, 2020: 3M Company: Departure of directors or certain officers 193
9.1.6 Jan 08, 2020: Midatech Pharma: Positive results from MTD201-102 study support subcutaneous route for long-acting octreotide product 194
9.1.7 Jan 08, 2020: Anavex Life Sciences issued new U.S. patent for ANAVEX2-73 treatment of Neurodevelopmental Disorders including Rett Syndrome and Multiple Sclerosis 195
9.1.8 Dec 19, 2019: World-Renowned Neurosurgeon selected to lead nationally-recognized Henry Ford Medical Group 196
9.1.9 Dec 16, 2019: Jean-Claude Dubacher named Chairman and Chief Executive Officer of B. Braun Medical 197
9.1.10 Dec 05, 2019: Johnson & Johnson names Hubert Joly, Executive Chairman of Best Buy and Mark A. Weinberger, Former EY Global Chairman and CEO to its Board of Directors 198
9.1.11 Nov 27, 2019: Luna Innovations names Gene Nestro as Chief Financial Officer 199
9.1.12 Nov 26, 2019: Dr. Emanual Maverakis, recipient of presidential award for scientists and engineers, joins RenovaCare 200
9.1.13 Nov 18, 2019: RenovaCare appoints Alan L. Rubino as President and CEO 201
9.1.14 Oct 14, 2019: Anika appoints Mira Leiwant as vice president of regulatory affairs, quality, and clinical affairs 202
9.1.15 Oct 08, 2019: Klox Technologies announces the appointment of Mr. Domenic Serafino and Dr. Richard Markoff to its Board of Directors 202
9.1.16 Oct 07, 2019: Xtant Medical names Sean Browne President and Chief Executive Officer 203
9.1.17 Oct 01, 2019: Sonoma Pharmaceuticals announces Management Changes 204
9.1.18 Sep 30, 2019: Johnson & Johnson appoints Carlton Lawson to area Managing Director, Consumer, Northern Europe 204
9.1.19 Sep 24, 2019: Dr. Frank Gerberick, Procter & Gamble product safety veteran, joins RenovaCare 205
9.1.20 Sep 16, 2019: NovaBay Pharmaceuticals names Finance Executive Jeff Zheng to its Board of Directors 206
9.1.21 Sep 13, 2019: FDA clears GE’s AI algorithms to identify pneumothorax 206
9.1.22 Sep 06, 2019: Cytokinetics to present on its Hypertrophic Cardiomyopathy drug candidate CK-274 at 23rd Annual HFSA Scientific Meeting 208
9.1.23 Sep 05, 2019: Mary Beth Vitale appointed to Luna Innovations board of directors 209
9.1.24 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership 209
9.1.25 Aug 26, 2019: GT Medical Technologies to be honored with an AZBio Fast Lane Award 210
9.1.26 Aug 20, 2019: Dr. Robin Robinson, founding director of BARDA joins RenovaCare 211
9.1.27 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 213
9.1.28 Jul 22, 2019: Adynxx adds Gregory J. Flesher to board of directors, completes up-listing to OTCQB market 214
9.1.29 Jul 08, 2019: Anika appoints James Loerop as executive vice president of business development and strategic planning 214
9.1.30 Jul 01, 2019: Medline mourns passing of co-founder Jim Mills 215
9.1.31 Jun 24, 2019: Integra LifeSciences announces promotion of Glenn Coleman to newly-created role of chief operating officer and appointment of Carrie Anderson as chief financial officer 216
9.1.32 Jun 20, 2019: ACell receives supplier legacy award from Premier 217
9.1.33 Jun 17, 2019: NovaBay Pharmaceuticals appoints Justin Hall President and CEO, and Jason Raleigh CFO 218
9.1.34 Jun 17, 2019: Joerns adds Vice President of Human Resources to support company's growth 218
9.1.35 May 17, 2019: Ironshore Pharmaceuticals to showcase JORNAY PM (Methylphenidate HCl) CII at the 2019 American Psychiatric Association Meeting 219
9.2 Financial Announcements 220
9.2.1 Mar 03, 2020: GenSight Biologics announces presentation of bilateral visual recovery from GS010 (LUMEVOQ) Phase III trials at the 46th annual meeting of NANOS 220
9.2.2 Mar 02, 2020: Covalon announces first quarter fiscal 2020 results 222
9.2.3 Feb 19, 2020: Integra LifeSciences reports fourth quarter and full-year 2019 financial results and provides 2020 financial guidance 223
9.2.4 Feb 14, 2020: Sonoma Pharmaceuticals reports third quarter FY 2020 financial results 224
9.2.5 Jan 29, 2020: Avery Dennison announces fourth quarter and full year 2019 results 226
9.2.6 Jan 22, 2020: Johnson & Johnson reports 2019 fourth-quarter and full year results 227
9.2.7 Jan 17, 2020: Scandinavian ChemoTech receives its first order from their new distributor in India 228
9.2.8 Jan 15, 2020: SomaLogic adds three new SomaSignal tests to its current offerings 229
9.2.9 Jan 13, 2020: Misonix reports preliminary fiscal 2020 second quarter revenue of approximately $19.7 million 231
9.2.10 Dec 31, 2019: Belgium customers select C-RAD’s innovative SIGRT solution 231
9.2.11 Dec 18, 2019: Terason partners with AmCad BioMed to provide more efficient solutions to assess and diagnose obstructive sleep apnea 234
9.2.12 Nov 15, 2019: SANUWAVE health reports third quarter 2019 financial results 236
9.2.13 Nov 14, 2019: Sonoma Pharmaceuticals reports second quarter FY 2020 financial results 238
9.2.14 Nov 07, 2019: NovaBay Pharmaceuticals reports 2019 third quarter financial results 239
9.2.15 Nov 07, 2019: Xtant Medical announces third quarter 2019 financial results 241
9.2.16 Nov 05, 2019: Luna Innovations reports strong third-quarter 2019 results 242
9.2.17 Oct 24, 2019: Integra LifeSciences reports third quarter 2019 financial results 243
9.2.18 Oct 24, 2019: Anika reports third quarter 2019 financial results 244
9.2.19 Oct 15, 2019: Johnson & Johnson reports 2019 Third-Quarter Results 245
9.2.20 Aug 28, 2019: Covalon announces third quarter fiscal 2019 results 246
9.2.21 Aug 15, 2019: SANUWAVE Health reports second quarter 2019 financial results 247
9.2.22 Aug 14, 2019: Misonix reports fourth quarter and fiscal year 2019 results 249
9.2.23 Aug 13, 2019: Sonoma pharmaceuticals reports first quarter FY 2020 financial results 251
9.2.24 Aug 08, 2019: Xtant Medical announces second quarter 2019 financial results 252
9.2.25 Aug 07, 2019: NovaBay Pharmaceuticals reports 2019 second quarter financial results 253
9.2.26 Aug 01, 2019: KIYATEC Assay hits the mark in study to predict patient response to first line ovarian cancer drugs 254
9.2.27 Jul 24, 2019: Integra LifeSciences reports second quarter 2019 financial results 255
9.2.28 Jul 24, 2019: Anika reports second quarter 2019 financial results 256
9.2.29 Jul 22, 2019: Study investigates the ability of continuous noninvasive hemoglobin monitoring with Masimo SpHb to reflect acute hemodilution during incremental fluid administration 258
9.2.30 Jul 16, 2019: Johnson & Johnson reports 2019 Second-Quarter Results 259
9.2.31 Jul 08, 2019: Sonoma Pharmaceuticals reports fiscal year and fourth quarter 2019 financial results 260
9.2.32 May 28, 2019: Covalon announces second quarter fiscal 2019 results 261
9.2.33 May 22, 2019: Portola Pharmaceuticals announces new analysis from the ANNEXA-4 study of its Factor Xa inhibitor reversal agent andexxa in patients with spontaneous (Non-Traumatic) intracranial hemorrhage 262
9.2.34 May 21, 2019: Sanuwave Health reports first quarter 2019 financial results 264
9.2.35 May 15, 2019: Xtant Medical announces first quarter 2019 financial results 266
9.3 Legal And Regulatory 267
9.3.1 Dec 03, 2019: Ferris Mfg. Corp. is pleased to announce settlement with an unauthorized distributor of its medical products 267
9.3.2 Jun 20, 2019: SEC investigation of Misonix ends with no action 267
9.4 Other Significant Developments 268
9.4.1 Apr 16, 2020: GEMCORE adapts wound dressing to help protect healthcare workers from friction injuries caused by personal protective equipment and donates 8,000 units 268
9.4.2 Apr 08, 2020: Anika takes actions to strengthen liquidity in light of covid-19 269
9.4.3 Mar 31, 2020: Aroa Biosurgery opens new pathway for advanced wound treatment amidst covid-19 disruption in the United States 269
9.4.4 Jan 23, 2020: Johnson & Johnson announces $250 million commitment to support Frontline Health Workers, reaching 100 million people by 2030 270
9.4.5 Jan 13, 2020: Healthpeak announces lease with Johnson & Johnson Subsidiary at The Shore at Sierra Point 271
9.4.6 Oct 29, 2019: Dissolution of a wholly-owned subsidiary–Clearbridge Health USA 271
9.4.7 Aug 21, 2019: Joerns Healthcare completes reorganization plans 272
9.4.8 Jul 29, 2019: NovaBay Pharmaceuticals reports 2019 second quarter net sales of $1.8 million 272
9.4.9 Jul 26, 2019: Court confirms reorganization plan for Joerns Healthcare 272
9.4.10 Jul 25, 2019: Covalon CEO provides corporate update 273
9.4.11 Jun 18, 2019: Pathway Health announces distribution agreement with Briggs Healthcare 274
9.4.12 May 24, 2019: NanoVibronix provides business update for the first quarter of 2019 274
9.4.13 May 15, 2019: Johnson & Johnson outlines strategy to deliver above-market growth at 2019 pharmaceutical business review 275
9.5 Product News 276
9.5.1 Dec 02, 2019: NanoVibronix to present at two investor conferences in December 276
9.5.2 Oct 04, 2019: MEI Pharma announces updated clinical data from ME-401 phase 1b study in patients with Indolent B-cell Malignancies 277
9.6 Strategy And Business Planning 278
9.6.1 Jan 16, 2020: New Bloomfield Township Medical Center: Enhancing the care experience 278
9.6.2 Dec 13, 2019: 3M to divest drug delivery business to Altaris Capital in $650m deal 279
9.6.3 Aug 01, 2019: SeaSpine announces the launch of the Shoreline RT Cervical Interbody Implant System, featuring Reef Topography 280
9.6.4 Jun 18, 2019: Study presented at American Diabetes Association 79th Scientific Sessions observed substantially less hypoglycemia with use of Glytec’s Technology 281
10 Appendix 282
10.1 Research Methodology 283
10.1.1 Coverage 283
10.1.2 Secondary Research 283
10.1.3 Primary Research 284
10.1.4 Market Modeling and Forecasting 285
10.1.5 Company Share Analysis 287
10.1.6 Distribution Share Analysis 287
10.1.7 Benchmarking 287
10.2 GlobalData Consulting 288
10.3 Contact Us 288
10.4 Disclaimer 28